Imagion Biosystems Limited
IBXXF
$0.01
$0.00-10.71%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -104.72% | 23.72% | 65.89% | 77.71% | 83.63% |
| Total Depreciation and Amortization | -97.83% | -98.51% | -98.77% | -81.32% | -67.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 234.39% | -80.21% | -209.96% | -132.04% | -65.02% |
| Change in Net Operating Assets | -810.69% | -128.33% | -95.14% | -95.14% | -95.14% |
| Cash from Operations | -211.21% | -82.18% | -16.17% | 62.24% | 84.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | 0.36% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | 100.00% | 130.87% | 144.12% |
| Total Debt Issued | -- | -74.23% | -59.02% | -74.15% | -79.43% |
| Total Debt Repaid | -- | 90.75% | 89.80% | 93.81% | 95.55% |
| Issuance of Common Stock | 12.00% | 30.03% | 58.64% | 43.59% | 31.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -34.03% | 4.05% | 30.51% | 57.09% | 68.96% |
| Cash from Financing | -10.90% | 7.19% | 37.66% | 3.70% | -16.28% |
| Foreign Exchange rate Adjustments | -204.44% | -463.64% | 111.39% | 184.62% | 742.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -131.04% | -109.06% | 929.76% | 170.11% | 156.73% |